Seer Quote - SEER

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.39

Bid

2.27

Ask

2.45

Volume

231,029

2.33 Day's Range 2.438

1.51 52 Week Range 2.625

Market Cap

140.93M

Previous Close

2.41

Open

2.40

Last Trade

2.39

Last Trade Time

Financial Volume

US$ 548,478

VWAP

2.3741

Average Volume (3m)

235,786

Shares Outstanding

58,966,560

Dividend Yield

PE Ratio

-1.63

Earnings Per Share (EPS)

-1.46

Revenue

16.66M

Net Profit

-86.28M

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.seer.bio

Headquarters

Wilmington, Delaware, USA

Founded

Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was US$2.41. Over the last year, Seer shares have traded in a share price range of US$ 1.51 to US$ 2.625.

Seer currently has 58,966,560 shares outstanding. The market capitalization of Seer is US$142.11 million. Seer has a price to earnings ratio (PE ratio) of -1.63.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it...

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.06	2.57510729614	2.33	2.415	2.26	116507	2.33862958	CS
4	0.22	10.1382488479	2.17	2.495	2.145	188660	2.34518571	CS
12	0.48	25.1308900524	1.91	2.625	1.89	235786	2.33984132	CS
26	0.345	16.8704156479	2.045	2.625	1.585	267951	2.01148451	CS
52	0.71	42.2619047619	1.68	2.625	1.51	406145	1.88335552	CS
156	-12.9	-84.3688685415	15.29	18.22	1.455	377349	4.70142208	CS
260	-45.61	-95.0208333333	48	86.55	1.455	409661	16.47225736	CS

SEER - Frequently Asked Questions (FAQ)

What is the current Seer share price?

The current share price of Seer is US$ 2.39

How many Seer shares are in issue?

Seer has 58,966,560 shares in issue

What is the market cap of Seer?

The market capitalisation of Seer is USD 142.11M

What is the 1 year trading range for Seer share price?

Seer has traded in the range of US$ 1.51 to US$ 2.625 during the past year

What is the PE ratio of Seer?

The price to earnings ratio of Seer is -1.63

What is the cash to sales ratio of Seer?

The cash to sales ratio of Seer is 8.46

What is the reporting currency for Seer?

Seer reports financial results in USD

What is the latest annual turnover for Seer?

The latest annual turnover of Seer is USD 16.66M

What is the latest annual profit for Seer?

The latest annual profit of Seer is USD -86.28M

What is the registered address of Seer?

The registered address for Seer is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Seer website address?

The website address for Seer is www.seer.bio

Which industry sector does Seer operate in?

Seer operates in the LAB ANALYTICAL INSTRUMENTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M